Zemplar

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This intravenous formulation supports calcium balance and bone health. Ideal for dialysis patients requiring PTH regulation. Short-term therapy may be indicated for certain conditions.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease, especially those on dialysis. It helps regulate parathyroid hormone levels to maintain calcium and phosphate balance. The medication is also used to prevent and manage elevated PTH in certain pre-dialysis patients under medical supervision.

Paricalcitol works by mimicking the action of vitamin D in the body, which helps control parathyroid hormone secretion. Patients may notice improved calcium levels and reduced bone discomfort over time. Some individuals report better energy levels as their mineral balance stabilizes.

Paricalcitol should be administered under medical supervision due to the risk of elevated calcium levels. Regular blood tests are recommended to monitor calcium, phosphate, and parathyroid hormone levels during treatment. Patients with a history of high calcium should use this medication with caution.

Paricalcitol may interact with medications that affect calcium metabolism, such as thiazide diuretics or calcium supplements. CYP3A inhibitors, including certain antifungals and antibiotics, may increase paricalcitol levels. Always inform your healthcare provider about all medications being taken.